The ingredient aligns with multiple high-growth narratives simultaneously, which is one reason it has become increasingly attractive to both established nutraceutical companies and emerging wellness brands
It is not available as a licensed medicine through the NHS, and it is not listed in the British National Formulary (BNF)
Non-pharmacological strategies like optimised nutrition and physical activity remain foundational, but new drug classes including GLP-1RAs and SGLT2 inhibitors are expanding treatment options
Zhao, Y., Li, X., Zhang, H., Cui, J., Wang, J., Chen, M., & Li, J
Clinical Impact of ITCA 650, a novel drug-device GLP-1 receptor agonist, in uncontrolled type 2 diabetes and very high baseline HbA1c: The FREEDOM-1 HBL (high baseline) study
Data processing and 3D reconstructions Dose-fractionated image stacks were subjected to beam-induced motion correction using MotionCor2.1